Simultaneous Intake of Chlorella and Ascidian Ethanolamine Plasmalogen Accelerates Activation of BDNF–TrkB–CREB Signaling in Rats

Hideo Takekoshi,Masaki Fujishima,Taiki Miyazawa,Ohki Higuchi,Takahiko Fujikawa,Teruo Miyazawa
DOI: https://doi.org/10.3390/molecules29020357
IF: 4.6
2024-01-12
Molecules
Abstract:Brain-derived neurotrophic factor (BDNF) plays an important role in neurogenesis, synaptic plasticity, and cognition. BDNF is a neurotrophin that binds to tropomyosin receptor kinase B (TrkB), a specific receptor on target cell surfaces; it acts on neuronal formation, development, growth, and repair via transcription factors, such as cAMP response element-binding protein (CREB), and it is involved in learning and memory. BDNF expression is decreased in patients with Alzheimer's disease (AD). Exercise and the intake of several different foods or ingredients can increase BDNF expression, as confirmed with lutein, xanthophylls (polar carotenoids), and ethanolamine plasmalogen (PlsEtn), which are present at high levels in the brain. This study examined the effects of combining lutein and PlsEtn using lutein-rich Chlorella and ascidian extracts containing high levels of PlsEtn bearing docosahexaenoic acid, which is abundant in the human brain, on the activation of the BDNF–TrkB–CREB signaling pathway in the hippocampus of Sprague-Dawley rats. Although activation of the BDNF–TrkB–CREB signaling pathway in the hippocampus was not observed in Chlorella or ascidian PlsEtn monotherapy, activation was observed with combination therapy at an equal dose. The results of this study suggest that the combination of Chlorella and ascidian PlsEtn may have a preventive effect against dementia, including AD.
chemistry, multidisciplinary,biochemistry & molecular biology
What problem does this paper attempt to address?
The paper attempts to address whether the combined intake of spirulina (Chlorella) and ascidian ethanolamine phospholipids (PlsEtn) can accelerate the activation of the brain-derived neurotrophic factor (BDNF)-TrkB-CREB signaling pathway in the hippocampus of rats. Specifically, the researchers aim to verify through this study whether the combination of spirulina and ascidian ethanolamine phospholipids can activate this signaling pathway more effectively than when used alone, thereby potentially having a positive effect on the prevention of dementia, including Alzheimer's disease (AD). ### Background Information: 1. **Dementia**: Globally, the number of dementia patients is continuously increasing. In Japan, the number of dementia patients aged 65 and above is expected to reach approximately 8 million by 2040. 2. **Alzheimer's Disease (AD)**: Among dementia patients in Japan, about 65-70% have Alzheimer's disease. The main theory of AD is the amyloid hypothesis, which suggests that the accumulation of amyloid-beta in the brain leads to neuronal degeneration. 3. **BDNF-TrkB-CREB Signaling Pathway**: BDNF is an important neurotrophic factor involved in neurogenesis, synaptic plasticity, and cognitive function. BDNF activates downstream transcription factors such as CREB by binding to its specific receptor TrkB, thereby promoting the formation, development, growth, and repair of neurons. The expression of BDNF in the hippocampus and temporal lobe is reduced in AD patients. 4. **Spirulina and Ascidian Ethanolamine Phospholipids**: Spirulina is rich in lutein, and ascidians are rich in ethanolamine phospholipids (PlsEtn) containing docosahexaenoic acid (DHA). These components are highly present in the brain and may have a positive effect on neuroprotection. ### Research Objectives: - **Verify Combined Effect**: The researchers aim to verify whether the combined intake of spirulina and ascidian ethanolamine phospholipids can activate the BDNF-TrkB-CREB signaling pathway more effectively than when used alone. - **Prevent Dementia**: If the combined intake can significantly activate this signaling pathway, then this combination may have a potential positive effect on the prevention of dementia, particularly Alzheimer's disease. ### Experimental Design: - **Experimental Groups**: - **Control Group (Con)**: No supplements given. - **Spirulina Group (CHL)**: Given 200 mg of spirulina powder daily. - **Ascidian Ethanolamine Phospholipids Group (HRE)**: Given 0.07 mg of ascidian ethanolamine phospholipids daily. - **Combined Group (Mix)**: Given 200 mg of spirulina powder and 0.07 mg of ascidian ethanolamine phospholipids daily. - **Detection Indicators**: The expression and phosphorylation levels of BDNF, pTrkB, and pCREB in the hippocampus were detected by Western blotting. ### Results: - **BDNF Expression**: The BDNF protein expression level in the combined group (Mix) was significantly higher than in the groups using spirulina or ascidian ethanolamine phospholipids alone, with an increasing trend. - **TrkB Phosphorylation**: The TrkB phosphorylation level in the combined group (Mix) was significantly higher than in the control group and the spirulina group. - **CREB Phosphorylation**: The CREB phosphorylation level in the combined group (Mix) was significantly higher than in all other groups. ### Discussion: - **Synergistic Effect**: The results suggest that the combined intake of spirulina and ascidian ethanolamine phospholipids can significantly activate the BDNF-TrkB-CREB signaling pathway, possibly due to a synergistic effect between the two. - **Mechanism Exploration**: Although the specific mechanism is not yet clear, the researchers speculate that the ethanolamine phospholipids in PlsEtn may promote the absorption of lutein, and the vitamin B12 in spirulina may promote the biosynthesis and antioxidant protection of ethanolamine phospholipids. ### Conclusion: The results of this study indicate that the combined intake of spirulina and ascidian ethanolamine phospholipids can significantly activate the BDNF-TrkB-CREB signaling pathway in the hippocampus of rats, which may have a potential positive effect on the prevention of dementia, especially Alzheimer's disease. Future research will further explore the specific mechanisms of this combination and its potential application in humans.